AfterNext HealthTech Acquisition Trims Deal Size 17% Ahead of $250M IPO

The contemplated transaction will result in the existing Stonepeak note, totaling approximately $470 million, being cancelled and converted into shares of the company. In addition, Stonepeak will invest $130 million in new money into the company as a capital contribution.

WindRose financed the transaction, which included commitments from WindRose's sixth fund as well as a new WindRose vehicle capitalized and led by StepStone Group and joined by other new and existing investors.